LLY Competitors & Rivals

Compare Eli Lilly and Company with top Drug Manufacturers - General companies

Eli Lilly and Company

LLY - Healthcare

Market Cap

$969.1B

Price

$1077.19

P/E Ratio

52.91

Revenue Growth

0.5%

View Details

Top Competitors

Apple Inc

AAPL

$261.05

Market Cap

$3874.1B

P/E Ratio

34.84

Rev Growth

0.1%

Microsoft Corp

MSFT

$470.67

Market Cap

$3498.6B

P/E Ratio

33.89

Rev Growth

0.2%

Alphabet Inc Class A

GOOGL

$335.97

Market Cap

$4019.5B

P/E Ratio

32.79

Rev Growth

0.2%

Amazon Com Inc

AMZN

$242.60

Market Cap

$2634.8B

P/E Ratio

34.86

Rev Growth

0.1%

Side-by-Side Comparison

MetricLLYAAPLMSFTGOOGL
Price$1077.19$261.05$470.67$335.97
Market Cap$969.1B$3874.1B$3498.6B$4019.5B
P/E Ratio52.9134.8433.8932.79
Revenue Growth0.5%0.1%0.2%0.2%
Profit Margin0.3%0.3%0.4%0.3%

Detailed Head-to-Head Comparisons

Get in-depth analysis comparing LLY with each competitor

Frequently Asked Questions

Who are LLY's main competitors?

LLY's main competitors include AAPL, MSFT, GOOGL, and other companies in the Drug Manufacturers - General industry. These companies compete directly with Eli Lilly and Company for market share and customers.

How does LLY compare to its competitors?

LLY can be compared to competitors using metrics like market capitalization, P/E ratio, revenue growth, profit margins, and market share. Each competitor has different strengths - some may have better valuations while others have higher growth rates.

What are the best alternatives to LLY stock?

The best alternatives to LLY depend on your investment goals. For similar market exposure, consider AAPL or MSFT. For different risk profiles, research companies with varying market caps and growth trajectories in the Drug Manufacturers - General sector.

Which is better: LLY or AAPL?

Comparing LLY vs AAPL requires analyzing valuation metrics, growth prospects, competitive advantages, and risk factors. Neither is universally "better" - the right choice depends on your investment strategy, risk tolerance, and market outlook.

What makes LLY different from its competitors?

Eli Lilly and Company differentiates itself through its unique business model, product offerings, market positioning, and competitive advantages. Factors like brand strength, innovation, operational efficiency, and financial health distinguish LLY from rivals.

Should I diversify across LLY and its competitors?

Diversifying across multiple companies in the same industry can reduce company-specific risk while maintaining sector exposure. However, this doesn't eliminate sector risk. Consider diversifying across different industries and sectors for better risk-adjusted returns.

Continue Your Research

Explore more analysis tools for LLY

Explore Categories